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summARy – Autoimmune polyglandular syndrome by definition consists of two or more en-
docrinological insufficiencies or two organ specific autoimmune diseases. There are no stringent cri-
teria for endocrinological evaluation of patients with one endocrine insufficiency. however, detailed 
endocrinological evaluation should be undertaken in patients with two autoimmune diseases. Addi-
tionally, follow up thereafter should be a must in these patients in order to avoid the possibility of not 
diagnosing subsequent autoimmune diseases that can occur. The aim of this case report is to point to 
the necessity of endocrinological screening to be made in patients presenting with gastric carcinoid 
type 1. we report on a 62-year-old woman who was diagnosed with primary hypothyroidism in 
1993. in 2011, she was re-admitted to the hospital due to increasing fatigue. macrocytic anemia, 
low vitamin B12 levels and positive parietal antibodies confirmed pernicious anemia. Furthermore, 
she underwent gastroscopy, which revealed two polyps in the corpus of the stomach and one in the 
fornix. endoscopic mucosal resection was performed and histopathologic analysis confirmed three 
G1 gastric carcinoids (Ki67 2%). Additional endocrinological evaluation disclosed positive glutamic 
acid decarboxylase antibodies, but normal fasting and postprandial glucose and hbA1c. in 2013, 
she was diagnosed with glucose intolerance and subsequently with latent autoimmune diabetes of 
adulthood. plasma glucose and hbA1c normalized after dietary intervention. due to the increase 
of serum chromogranin A, prophylactic antrectomy was performed in 2014. The patient is still fo-
llowed-up and has normal chromogranin A, gastrin and hbA1c levels. 
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Introduction
polyglandular autoimmune syndrome (pAs) is an 
accumulation of multiple endocrine gland insufficien-
cies or other organ specific autoimmune diseases1. There 
are two major types of pAs. type i is a monogenetic 
autoimmune disease which becomes fully manifested 
by the age of 202. type ii is a polygenetic disorder that 
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consists of two or more endocrine or other autoim-
mune organ specific diseases3. A novel classification 
suggests additional division to pAs type ii, iii and 
iv1. According to the new classification, pAs type ii 
consists of Addison’s disease, diabetes mellitus type 
1 and autoimmune thyroid disease. pAs type iii ex-
cludes the presence of Addison’s disease and is further 
divided into category iiiA (autoimmune thyroiditis 
with immune-mediated diabetes), iiiB (autoimmune 
thyroiditis with pernicious anemia) and iiiC (autoim-
mune thyroiditis with vitiligo and/or alopecia and/or 
other organ specific disease). organ specific diseases 
include celiac disease, hypogonadism and myasthe-
nia gravis, while organ non-specific diseases include 
sarcoidosis, sjögren’s syndrome and rheumatoid ar-
thritis1. pAs type iv consists of two organ specific 
diseases and/or organ non-specific diseases1. A great 
deal of controversy exists about the novel classifica-
tion and it has not been fully established4. There are 
no stringent criteria for endocrinological evaluation of 
patients with one endocrine insufficiency. however, 
detailed endocrinological evaluation should be un-
dertaken in patients with two autoimmune diseases3. 
Additionally, follow up thereafter should be a must in 
these patients in order to avoid the possibility of not 
diagnosing subsequent autoimmune diseases that can 
occur3.
Autoimmune gastritis, eventually leading to per-
nicious anemia, is an organ specific autoimmune 
disease characterized by pathological lesions affect-
ing the fundus and body of the stomach, which are 
typified by gastric mucosal atrophy, selective loss of 
parietal cells from the gastric mucosa, submucosal 
lymphocytic infiltration, as well as circulating gastric 
parietal cell autoantibodies5. subsequently, pernicious 
anemia, which is considered to be the most common 
cause of vitamin B12 deficiency, may develop. more-
over, gastric parietal cell antibodies induce apoptosis 
in parietal cells, which leads to achlorhydria and com-
pensatory increase in serum gastrin levels. Chronic 
hypergastrinemia stimulates enterochromaffin-like 
cells, which eventually leads to enterochromaffin-like 
cell hyperplasia and gastric carcinoid type 1. howev-
er, the prevalence of gastric carcinoid in patients with 
pernicious anemia is less than 1%6. 
we report on a 62-year-old woman with a history 
of hypothyroidism who presented with pernicious 
anemia and gastric carcinoid type 1. screening for 
other components of pAs ii revealed high antibody 
titers to decarboxylic glutaminic acid. The patient was 
diagnosed with glucose intolerance two years later. 
Case Report
A 62-year-old female patient with a medical histo-
ry of autoimmune thyroid disease accompanied with 
hypothyroidism was admitted in 2011 due to increas-
ing fatigue and newly diagnosed macrocytic anemia. 
The patient had been diagnosed with primary hy-
pothyroidism in 1993 and had been well substituted 
with levothyroxine ever since. physical examination 
was unremarkable. laboratory examinations revealed 
hemoglobin level of 130 g/l and mean cell volume of 
120 fl. Further testing showed decreased vitamin B12 
Fig. 1. A 13 mm large carcinoid in the fornix of the stomach (A); endoscopic mucosal resection of the tumor (B).
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level of 78 ng/l (normal range: 211-911) along with 
positive parietal cell antibodies. electrolytes and the 
rest of the complete blood count (CBC) panel were 
within the normal reference values. 
upper gastrointestinal (Gi) endoscopy revealed 
three polyps within the gastric wall. two small pol-
yps were located in the corpus of the stomach and 
one approximately 10 mm large polyp was found in 
the fornix of the stomach (Fig. 1A). since the patient 
had pernicious anemia, we presumed the polyps to be 
carcinoid tumors. hence, we performed endoscopic 
ultrasound in order to assess invasion into the gastric 
wall. All three polyps seemed to be limited to the sub-
mucosa, and therefore endoscopic mucosal resection 
was performed (Fig. 1B). histopathologic examina-
tion confirmed two 6 mm large G1 carcinoids (Ki67 
2%) (Fig. 2A-d) in the corpus and one 13 mm large 
G1 carcinoid in the fornix of the stomach (Ki67 2%). 
There were signs of muscularis propria invasion by the 
largest polyp, and margins of the resected polyp were 
negative. in order to assess the presence of locore-
gional and distant metastases, we performed 99tech-
netium scintigraphy, which revealed two focal lesions 
in the mediastinum. however, multislice computed 
tomography showed normal findings. 
detailed endocrinological evaluation demon-
strated a gastrin level of 22000 pg/ml (normal range: 
13-115), chromogranin A 88 mcg/l (normal <100) , 
ACth 8.98 pmol/l (normal <13.3), morning cortisol 
607 nmol/l (normal range: 171-536), 17-hour cortisol 
155 nmol/l (normal range: 64-327), t3 1.54 nmol/l 
(normal range: 1.1-3.1), t4 92.1 nmol/l (normal 
Fig. 2. Round nests of tumor cells with uniform nuclei surrounded with fibrovascular stroma, hematoxylin-eosin ×400 
(A); positive synaptophysin (B) and chromogranin (C) expression, ×100; positive Ki67 expression in approximately 2% 
of tumor cells, ×400 (D). 
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range: 60-165), tsh 1.19 miu/l (normal range: 0.4-
4.0), antitpo >600.0 miu/l (normal range: <50), 
lh 26.0 iu/l (normal range: 7.7-58.5), and Fsh 
39.5 iu/l (normal range: 25.8-134.8).
since our patient had two autoimmune diseases, 
we measured other organ specific antibodies available 
in our hospital. Antibodies to glutamic acid decarbox-
ylase (GAdA) were increased to 87.5 u/ml (normal 
<1.0). however, her hbA1c was within the normal 
limits (5.4%, normal range <6%), as well as fasting 
and postprandial glucose. 
vitamin B12 in a dose of 1000 mcg intramuscular-
ly was administered regularly, and thereafter her CBC 
panel was within the normal ranges. Blood glucose 
and hbA1c were also regularly checked since the pa-
tient had positive GAd antibodies. in 2013, we found 
fasting glucose of 5.9 mmol/l, postprandial glucose 
of 8 mmol/l and hbA1c of 6.1%. This indicated glu-
cose intolerance and prediabetes. dietary measures 
were prescribed, after which fasting and postprandial 
glucose and hbA1c normalized. 
during three-year follow up, upper Gi endoscopy 
showed no signs of residual tumor mass or recurrence. 
however, chromogranin A levels increased to 145 
mcg/l three years after polypectomy. multislice com-
puted tomography, magnetic resonance imaging and 
99technetium-sestimibe scintigraphy showed normal 
findings. however, we decided to perform antrectomy 
in order to reduce the risk of local recurrence and dis-
tant metastasis. serum gastrin decreased to 54 pg/ml 
and chromogranin A decreased to 5 mcg/l.
Discussion
This is the first case of a patient with gastric carci-
noid type i in whom screening for other components 
of pAs disclosed positive GAdA antibodies and an 
early stage of latent autoimmune diabetes of adult-
hood (lAdA). 
latent autoimmune diabetes of adulthood de-
scribes patients with a type 2 diabetic phenotype 
combined with islet antibodies and slowly progressive 
β-cell failure7. lAdA patients are not insulin depen-
dent during the first few years after the diagnosis of 
diabetes. however, β-cell function gets impaired over 
the period of six years, which leads to insulin depen-
dency in most lAdA patients7. high titers of islet 
antibodies correlate positively with β-cell failure8. in 
a study by Borg et al., 67% of patients with GAdA 
levels above 41.4 u/ml developed insulin dependent 
diabetes mellitus over the period of 5 years9. our pa-
tient had a GAdA level of 87.5 u/ml at the time 
of screening, and was diagnosed with prediabetes two 
years later. Based on a high titer of GAdA, it is most 
likely that the patient will develop insulin dependent 
diabetes mellitus despite dietary and lifestyle changes. 
Therefore, measurement of GAdA is of great value 
for early diagnosis and treatment of lAdA. how-
ever, screening for lAdA should not have been made 
in our patient based on the new classification of pAs. 
older classification of pAs recognizes only type i and 
type ii. type ii is defined by the presence of two or-
gan specific or non-organ specific autoimmune dis-
eases3. The new classification of pAs defines type ii 
as the coexistence of autoimmune thyroid disease and 
type 1 diabetes mellitus or Addison’s disease1. older 
type ii pAs is then subdivided into type iii and iv 1. 
type iii is associated with thyroid autoimmunity and 
other autoimmune diseases, excluding Addison’s and 
type 1 diabetes. subclassification of type iii includes 
3A (autoimmune thyroiditis combined with immune 
mediated diabetes mellitus), 3B (autoimmune thy-
roiditis with pernicious anemia) and 3C (autoimmune 
thyroiditis with vitiligo or alopecia)1. type iv is de-
fined as two or more other organ specific autoimmune 
diseases1. we find the older classification to be more 
appropriate. The diagnosis of pAs type iiiB could be 
made in our patient in 2011. since type iiiB does not 
involve other organ specific diseases, we did not have 
to screen the patient for other autoimmune diseases. 
we suggest that pAs type ii is a spectrum of several 
autoimmune diseases and that the combination of all 
diseases is possible. Clear and more straightforward 
guidelines need to be proposed to avoid any sort of 
misguidance and to give a pinpoint diagnosis. to di-
agnose type 2 pAs, patients must present minimally 
with two endocrine insufficiencies or two organ spe-
cific autoimmune diseases. The time frame of other 
insufficiencies presenting is impossible to predict, but 
with screening antibodies better prediction can be 
foreseen10. Therefore, we propose that antibodies be 
measured in patients with two or more autoimmune 
diseases. There are no strict guidelines for screening 
in patients with one endocrine insufficiency. we tend 
to agree with dittmar et al. who propose screening at 
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three-year intervals for patients with one endocrine 
insufficiency3. we believe that it will suffice to mea-
sure tsh, anti-tpo, morning cortisol and ACth, 
CBC, hbA1c and testosterone in men.
Gastric carcinoid type i is the most common 
type which accounts for approximately 70%-80% of 
all gastric carcinoids11. type ii is associated with the 
concomitant presence of gastrinoma and is encoun-
tered in 5% of patients. type iii carcinoids are defined 
as sporadic and are not related to hypergastrinemia11. 
type i carcinoids are mostly non-functional, low 
grade tumors with low malignant potential12. There-
fore, endoscopic polypectomy by snare or endoscopic 
mucosal resection (emR) is most appropriate treat-
ment for type i carcinoids13. in case of polyps >1 cm, 
endoscopic ultrasound should be performed to assess 
wall and lymph nodal invasion before polypectomy. 
surgery should be performed in case of involvement 
beyond the submucosa, or positive margins after 
emR13. type i carcinoids are often multiple and local 
recurrence is common, since hypergastrinemia associ-
ated with autoimmune gastritis is persistent14. in case 
of local recurrence or metastasis, antrectomy should 
be performed in order to reduce serum gastrin levels13. 
we initially performed emR for all carcinoids in our 
patient. Although local recurrence did not occur, a 
constant rise in serum chromogranin A levels was ob-
served. due to the increase in serum chromogranin A 
levels, we decided to perform antrectomy in our pa-
tient. The procedure was uneventful and both serum 
chromogranin A and gastrin normalized only three 
months after the surgery.
in conclusion, suspicion of gastric carcinoid must 
be raised in all patients with pernicious anemia and 
atrophic gastritis. Additionally, screening for other 
endocrinological deficiencies and autoimmune dis-
eases should be performed in all patients with gastric 
carcinoid type i. positive organ specific antibodies can 
facilitate an early diagnosis and treatment. 
References
1. eisenbarth Gs, Gottlieb pA. Autoimmune polyendocrine 
syndromes. n engl J med. 2004;350:2068-79.
2. Ahonen p, myllarniemi s, sipila i, perheentupa J. Clinical 
variation of autoimmune polyendocrinopathy-candidiasis-
ectodermal dystrophy (ApeCed) in a series of 68 patients. 
n engl J med. 1990;322:1829-36.
  3. dittmar m, Kahaly GJ. polyglandular autoimmune syn-
dromes: immunogenetics and long-term follow-up. J Clin 
endocrinol metab. 2003;88:2983-92. 
  4. eisenbarth Gs, Gottlieb pA. The immunoendocrinopathy 
syndromes. in: larsen pR, Kronenberg hm, melmed s, po-
lonsky Ks, eds. williams textbook of endocrinology. 10th 
ed. philadelphia: saunders, 2003:1763-76.
  5. Gleeson pA, toh Bh. molecular targets in pernicious anae-
mia. immunol today. 1991;12:233-8.
  6. Annibale B, Azzoni C, Corleto vd, di Giulio e, Caruana 
p, d’ambra G, et al. Atrophic body gastritis patients with en-
terochromaffin-like cell dysplasia are at increased risk for the 
development of type i gastric carcinoid. eur J Gastroenterol 
hepatol. 2001;13:1449-56. 
  7. stenström G, Gottsäter A, Bakhtadze e, Berger B, sund-
kvist G. latent autoimmune diabetes in adults: definition, 
prevalence, beta-cell function, and treatment. diabetes. 
2005;54:s68-72.
  8. littorin B, sundkvist G, hagopian w, landin-olsson m, 
lernmark Å, Östman J, et al. islet cell and glutamic acid de-
carboxylase antibodies present at diagnosis of diabetes predict 
the need for insulin treatment: a cohort study in young adults 
whose disease was initially labeled as type 2 or unclassifiable 
diabetes. diabetes Care. 1999;22:409-12.
  9. Borg h, Gottsäter A, landin-olsson m, Fernlund p, sund-
kvist G. high levels of antigen-specific islet antibodies pre-
dict future beta-cell failure in patients with onset of diabetes 
in adult age. J Clin endocrinol metab. 2001;86:3032-8.
10. lundgren vm, isomaa B, lyssenko v, laurila e, Korhonen 
p, Groop lC, et al. GAd antibody positivity predicts type 2 
diabetes in an adult population. diabetes. 2010;59:416-22.
11. Borch K, Ahrén B, Ahlman h, Falkmer s, Granérus G, 
Grimelius l. Gastric carcinoids: biologic behavior and prog-
nosis after differentiated treatment in relation to type. Ann 
surg. 2005;242:64-73.
12. Rindi G, Arnold R, Bosman Ft. nomenclature and classifi-
cation of neuroendocrine neoplasms of the digestive system. 
in: Bosman Ft, et al., eds. who Classification of tumours 
of the digestive system. lyon, iARC press, 2010, pp 13-4.
13. delle Fave G, Kwekkeboom dj, van Cutsem e, Rindi G, 
Kos-Kudla B, Knigge u, et al. enets Consensus Guide-
lines for the management of patients with gastroduodenal 
neoplasms. neuroendocrinology. 2012;95:74-87.
14. merola e, sbrozzi-vanni A, panzuto F, d’ambra G, di Giu-
lio e, pilozzi e, et al. type i gastric carcinoids: a prospective 
study on endoscopic management and recurrence rate. neu-
roendocrinology. 2012;95:207-13.
530 Acta Clin Croat,  Vol. 54,   No. 4,  2015
Ana Marija Vrkljan et al. Gastric carcinoid type 1 in a patient with autoimmune polyglandular syndrome
sažetak
KARCinoid želuCA tipA 1 u BolesniKA s Autoimunim poliGlAndulARnim sindRomom 
ZAhtiJevA dodAtne endoKRinološKe pRetRAGe
A. M. Vrkljan, D. Grašić, I. Kruljac, M. Nikolić, J. Filipović-Čugura, M. Ulamec, K. Kovačić, N. Babić i N. Ljubičić
Autoimuni poliglandularni sindrom čine dvije ili više endokrinih insuficijencija ili najmanje dvije za organ specifične 
autoimmune bolesti. ne postoje jasne smjernice za endokrinološko testiranje i praćenje bolesnika s jednom endokrinom 
insuficijencijom. Bolesnici s dvije endokrine insuficijencije ili za organ specifične autoimmune bolesti trebaju detaljnu en-
dokrinološku obradu kako bi se isključila mogućnost postojanja treće autoimmune bolesti. Cilj ovoga prikaza slučaja jest 
naglasiti nužnost dodatne endokrinološke obrade u bolesnika s karcinoidom želuca tipa 1. prikazujemo slučaj bolesnice 
kojoj je godine 1993. otkrivena primarna hipotireoza. Godine 2011. bolesnica je hospitalizirana zbog izražene opće slabo-
sti i malaksalosti. makrocitna anemija, nizak vitamin B12 i pozitivna protutijela na parijetalne stanice potvrdili su dija-
gnozu perniciozne anemije. Gornjom endoskopijom probavnog trakta otkrivena su dva polipa u korpusu i jedan u forniksu 
želuca. nakon endoskopskog ultrazvuka učinjena je endoskopska mukozektomija svih triju polipa. patohistološka analiza 
potvrdila je karcinoide gradusa 2 (Ki67 2%). dodatnim endokrinološkim testiranjem otkrivena su povišena protutijela na 
dekarboksilazu glutamata uz uredne vrijednosti glukoze u plazmi i hbA1c. Godine 2013. otkrivena je intolerancija glu-
koze te je postavljena dijagnoza latentnog autoimunog dijabetesa odrasle dobi. Glukoza u plazmi se normalizirala nakon 
higijensko-dijetetskih mjera. Zbog porasta kromogranina A u serumu učinjena je antrektomija godine 2014. Bolesnica sad 
ima uredan kromogranin A, gastrin i hbA1c.
Ključne riječi: Želučani tumori; Karcinoidni tumor; Poliendokrinopatije, autoimune; Anemija, perniciozna; Glukoza, into-
lerancija; Prikazi slučaja 
